Moreover, exploring the molecular mechanisms underlying their antidepressant effects, such as modulation of BDNF, neuroplasticity, and inflammatory pathways may provide important insights into novel therapeutic targets for treatment-resistant depression. This evidence concerns the gene BDNF and depressive symptom measurement.